Status:

COMPLETED

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

Lead Sponsor:

Gruppo Oncologico Italiano di Ricerca Clinica

Conditions:

Thromboembolism

Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a multicentric, phase IV study. In this study patients that are receiving an antineoplastic treatment and that have been diagnosed with venous thromboembolism will receive edoxaban as per clin...

Eligibility Criteria

Inclusion

  • Adult subjects presenting with VTE (venous thromboembolism) associated with cancer (other than basal-cell or squamous-cell carcinoma of the skin). Cancer diagnosis should be done within two years prior to VTE.
  • Patient must be receiving systemic antineoplastic therapy (such as chemotherapy, target therapy, immunotherapy, hormonotherapy) and remain candidate to receive at least other 3 months of anti neoplastic therapy.

Exclusion

  • Hypersensitivity to the active substance or to any of the excipients;
  • Clinically significant active bleeding;
  • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk;
  • Lesion or condition, if considered to be a significant risk for major bleeding. This may include current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities;
  • Uncontrolled severe hypertension;
  • Concomitant treatment with any other anticoagulants
  • Pregnancy and breast-feeding.

Key Trial Info

Start Date :

June 27 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 8 2022

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04072068

Start Date

June 27 2019

End Date

March 8 2022

Last Update

May 30 2023

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Presidio Ospedaliero SS. Antonio e Biagio

Alessandria, Italy

2

Istituto Tumori di Bari

Bari, Italy

3

Azienda Ospedalier Spedali Civili di Brescia

Brescia, Italy

4

Ospedale S.Giacomo

Castelfranco Veneto, Italy